Lars Hagmeyer

University of Cologne

Papers

2

Total Citations

39

H-Index

2

About

Dr. Lars Hagmeyer is a leading figure in interventional pulmonology and thoracic oncology, whose work centers on the minimally invasive diagnosis and treatment of lung cancer. His research is defined by two key areas: the application of advanced stereotactic body radiation therapy (SBRT) and the refinement of robotic bronchoscopy for peripheral pulmonary nodules. Dr. Hagmeyer’s major contribution is pioneering a "risk-adapted" approach to SBRT for inoperable early-stage non-small-cell lung cancer, a study that has garnered 36 citations and established a critical framework for tailoring radiation dose to patient-specific risks, improving outcomes for those unable to undergo surgery. More recently, he has advanced the field of bronchoscopic diagnostics with his 2025 work on integrated "tool-in-lesion" tomosynthesis within robotic navigation bronchoscopy. This innovation addresses the critical challenge of confirming tool placement during biopsy, aiming to increase diagnostic yield for small, hard-to-reach nodules. Through this combination of therapeutic optimization and diagnostic precision, Dr. Hagmeyer is shaping safer, more effective pathways for lung cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
39
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer
36 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Cologne

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago